20.03.2017 18:20:29
|
Array BioPharma Climbs Off Worst Levels But Continues To Post Notable Loss
(RTTNews) - Array BioPharma (ARRY) has climbed well off its worst levels but continues to post a notable loss in afternoon trading on Monday. Shares of Array are currently down by 5.3 percent after hitting a two-month intraday low.
The loss by Array comes after the biopharmaceutical company said it has withdrawn its new drug application for binimetinib monotherapy for the treatment of NRAS-mutant melanoma.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Array BioPharma Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |